Found: 7
Select item for more details and to access through your institution.
Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1618, doi. 10.1093/neuonc/nox097
- By:
- Publication type:
- Article
Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disorders.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Case report: Anti septin-5-encephalitis as a treatable cause of cerebellar ataxia and psychiatric symptoms.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1220295
- By:
- Publication type:
- Article
B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus Erythematosus.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 19, p. 10845, doi. 10.3390/ijms251910845
- By:
- Publication type:
- Article
Cytotoxic T cells and plasma cells dominate early in temporal lobe epilepsy with GAD antibodies.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 4, p. 1231, doi. 10.1093/brain/awad066
- By:
- Publication type:
- Article
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 2, p. 600, doi. 10.1093/brain/awac090
- By:
- Publication type:
- Article